People
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
27 February 2025 - Danish biotech company Adcendo announced on Wednesday that it has received approval from the US Food & Drug Administration (FDA) for its IND application for a Phase I study asse...
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
6 February 2025 - Australian biotechnology company Actinogen Medical Limited (ASX:ACW) announced on Wednesday that the World Health Organisation (WHO) has granted the non-proprietary name of 'eme...
IVFMD physicians named 2025 Castle Connolly Top Doctors
6 February 2025 - US-based fertility services provider IVFMD announced on Wednesday that five of its physicians have been honoured with 2025 Castle Connolly Top Doctors recognition.Castle Connolly Top...
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
4 February 2025 - Development stage healthcare delivery company HOPE Therapeutics Inc, a subsidiary of NRx Pharmaceuticals Inc (Nasdaq:NRXP), announced on Monday that it has appointed BTIG, a financia...
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
28 January 2025 - Life science tools company Partillion Bioscience Corporation announced on Monday that it has started taking pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits.The Mu...
Champions Oncology expands bioanalytical services with new technology
8 January 2025 - Oncology research company Champions Oncology Inc (NASDAQ: CSBR) announced on Wednesday that it has enhanced its clinical bioanalytical services portfolio by integrating Cytek Aurora f...